top of page

Tirzepatide Weight Loss Program

     

     Tirzepatide is a weight loss drug that recently had extensive clinical studies to prove its safety and efficacy.  It is an injectable medication that increases your satiety and reduces food intake. 

     Tirzepatide regulates blood sugar levels, enhances insulin sensitivity, and promotes weight loss.   It works by mimicking the effects of glucagon in your body, which helps slow down the emptying of your stomach and signals your brain that your stomach is full.   Consequently, you feel full and you eat less.

     Additionally,  Tirzepatide also influences metabolism by optimizing energy utilization, shifting the body's preference from glucose to fat as an energy source.    By enhancing insulin sensitivity and promoting fat burning, Tirzepatide aids in weight loss efforts and lessens the need to emotionally eat.

    Tirzepatide is an once a-week injection that you administer yourself at home.  The benefits help reduce hunger pangs and helps you lose weight faster when you combine injections with a low-calorie diet. 

  

 

To make an appointment please call Urgent Care of Conroe-- 936-521-2100

Close up of female doctor consulting with overweight patient, discussing test result in do

Qualifications 

Young woman standing on scales at home. Weight loss concept.jpg

Affordable Cost

Close up woman in blue shirt measuring her waist with yellow measuring tape. Weight loss,

Proven Results

Qualifications to enter the  Tirzepatide Weight Loss program:

​

1. Have a BMI or 25 or higher.

2. Between the ages of 19-70

3. Non-diabetic.

4. Not on another GLP-1 medication.

5. No history of medulary thyroid carcinoma or MEN2.

6. No history of pancreatitis.

7. Not pregnant or nursing.

​

Possible Side Effects:

​

1. Nausea

2. Vomiting

3. Diarrhea

4. Constipation

5. Abdominal pain

6. Decreased appetite

7. Indigestion

​

The majority of side effects are transient and typically resolve spontaneously.  However if you experience lingering side effects or have any stomach pain, etc. please do not hesitate to contact Dr. Kempton.

​

​

​

​

Patients will pay Urgent Care of Conroe for office visits.  The initial screening and physical exam is $145.00.   Follow up visits every month are $80.00. If a patient does not qualify, then a full refund will be issued.  Once the patient enters the program, Dr. Kempton will fax a prescription for Tirzepatide to the pharmacy.  Within 2 days, the pharmacy will reach out for payment from the patient and once payment is secured, the pharmacy will mail the medication in a cold pack in the next 5 days.   The medication will consist of a vial of Tirzepatide and 5-6 needles/syringes, alcohol swabs and instructions on how to inject. The medication is to given once a week until the vial is gone. Most patients are getting 4-6 weeks out of each vial.  The patient will be scheduled monthly to go over the weight loss progress, monitor blood sugar and any side effects and to receive a new prescription and a higher dose if needed.  The average price for Tirzepatide is $200- $250 depending on dosage.  Every patient starts the program on the same small dose.

The Tirzepatide Weight Loss program  is cash only.  We will not bill insurance. 

  

Clinical Studies and patient experience show that:

​

  • Average 15% reduction in body weight.

  • Average 6-inch reduction in waist size.

  • 92% achieve lasting weight loss.

  • 8 out of 10 patients say that it is more effective than anything they have ever tried.​

 

Patient testimonials:

 

   "I absolutely love it!  I have no cravings and I am not hunger.  I am losing weight and it has never been easier in my life!  Completely sold" 

                               --Melanie E.

​

  "I have tried everything to lose weight.  I would go a few days, and then life would happen, and I would go off my diet.  With this medication, I have no hunger and so I never feel like I am dieting.  I eat like a skinny person.  I am no longer thinking or feeling guilty about food.  I have lost 8lbs in a month."

​                            -- Janice K.

​

​

bottom of page